期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
血浆纤溶酶原激活物抑制剂-1、组织型纤溶酶激活物在胃癌侵袭与转移中的作用 被引量:3
1
作者 蔡芬 曾小菁 《中外医学研究》 2014年第7期57-58,共2页
目的:对血浆纤溶酶原激活物抑制剂-1(PAI-1)与组织型纤溶酶激活物(t-PA)在胃癌侵袭与转移中的作用进行研究。方法:选取28例胃癌患者设为病例组,另选取同期25例健康体检者设为对照组,采用酶联免疫吸附法检测上述检测者血浆标本PAI-1和t-P... 目的:对血浆纤溶酶原激活物抑制剂-1(PAI-1)与组织型纤溶酶激活物(t-PA)在胃癌侵袭与转移中的作用进行研究。方法:选取28例胃癌患者设为病例组,另选取同期25例健康体检者设为对照组,采用酶联免疫吸附法检测上述检测者血浆标本PAI-1和t-PA含量。结果:病例组血浆PAI-1含量明显高于对照组,差异有统计学意义(P<0.005);t-PA含量高于对照组,但差异无统计学意义(P>0.05)。胃癌患者血浆PAI-1含量在Ⅲ期明显高于Ⅳ期,差异有统计学意义(P<0.05);而血浆t-PA含量与胃癌TNM分期无关。血浆PAI-1含量在有淋巴结转移患者中最高,无淋巴结转移患者中次之,在正常对照组中最低,三者之间差异有统计学意义(P<0.05),说明血浆PAI-1含量与胃癌淋巴结转移相关,并随着淋巴结转移的产生而增高。血浆t-PA含量在三者之间比较差异无统计学意义(P>0.05),说明血浆t-PA含量与胃癌淋巴结转移无关。结论:PAI-1在胃癌的侵袭和转移中起重要的促进作用,PAI-1可以成为胃癌诊断和预后估计的指标。 展开更多
关键词 胃癌 激活物抑制剂-1 组织型纤溶酶激活物
下载PDF
中西医结合治疗脑梗死急性期对组织型纤溶酶原激活物及其抑制物的影响 被引量:5
2
作者 张汉明 《实用中医药杂志》 2017年第8期923-924,共2页
目的:观察中西医结合治疗脑梗死急性期对组织型纤溶酶原激活物(t-PA)及其抑制物(PAI)的影响。方法:82例随机分为对照组和观察组各41例。两组均用常规西药治疗,观察组加用化痰祛瘀汤。结果:观察组NIHSS评分、BI指数评分均显著优于对照组(... 目的:观察中西医结合治疗脑梗死急性期对组织型纤溶酶原激活物(t-PA)及其抑制物(PAI)的影响。方法:82例随机分为对照组和观察组各41例。两组均用常规西药治疗,观察组加用化痰祛瘀汤。结果:观察组NIHSS评分、BI指数评分均显著优于对照组(P<0.05),治疗后观察组t-PA和PAI指标均显著优于对照组(P<0.05)。结论:中西医结合治疗脑梗死急性期效果更好,可显著改善神经损伤程度,提高生活能力,促使t-PA水平升高及PAI水平降低。 展开更多
关键词 脑梗死急性期 中西医结合治疗 组织型纤溶酶激活物 组织型纤溶酶激活物抑制物
下载PDF
重组组织型纤溶酶原激活剂动脉内溶栓和血管内支架成形术治疗急性脑梗死 被引量:6
3
作者 贺道华 王伟民 +5 位作者 李林 王伟中 梁军潮 高寒 赵刚 白红民 《中国微侵袭神经外科杂志》 CAS 北大核心 2011年第12期532-534,共3页
目的评价重组组织型纤溶酶原激活剂(r-TPA)超选择动脉内溶栓和血管内支架成形术治疗急性脑梗死的临床疗效。方法回顾性分析45例急性脑梗死病人的临床资料,其中颈内动脉闭塞16例,大脑中动脉闭塞25例,椎-基底动脉闭塞4例。将微导管超选择... 目的评价重组组织型纤溶酶原激活剂(r-TPA)超选择动脉内溶栓和血管内支架成形术治疗急性脑梗死的临床疗效。方法回顾性分析45例急性脑梗死病人的临床资料,其中颈内动脉闭塞16例,大脑中动脉闭塞25例,椎-基底动脉闭塞4例。将微导管超选择送至血管闭塞部位,注入r-TPA行动脉内溶栓。其中血管明显狭窄7例,溶栓后采用支架血管内成形术。结果溶栓后完全再通31例,部分再通14例。治疗前欧洲卒中评分(European stroke scale,ESS)为(55.50±13.25),治疗后7 dESS评分为(90.85±15.36),两者有显著性差异(P<0.01)。7例血管明显狭窄者,支架置入术后血管残余狭窄<16%。结论 r-TPA早期超选择动脉内接触性溶栓,是治疗急性脑梗死的有效方法之一。对合并严重动脉狭窄的病人,动脉内溶栓结合血管内支架成形术安全可行。 展开更多
关键词 急性脑梗死 动脉内 组织型纤溶酶激活物 血管内治疗 支架
下载PDF
乳腺癌患者凝血纤溶状态的变化 被引量:2
4
作者 潘忠清 姜涛 《中国现代普通外科进展》 CAS 2009年第7期633-635,共3页
凝血与纤溶系统的异常是恶性肿瘤的重要生物学特征之一,某些指标已被公认为与肿瘤分化、分期、转移侵袭等部分生物学行为密切相关,高凝状态所并发的血栓形成也是目前恶性肿瘤患者最常见的并发症和主要死因。本研究通过检测乳腺癌患者... 凝血与纤溶系统的异常是恶性肿瘤的重要生物学特征之一,某些指标已被公认为与肿瘤分化、分期、转移侵袭等部分生物学行为密切相关,高凝状态所并发的血栓形成也是目前恶性肿瘤患者最常见的并发症和主要死因。本研究通过检测乳腺癌患者的血浆凝血酶原时间(prothrombin time,PT)、活化部分凝血酶时间(activated partial thromboplastin time,APTT)、 展开更多
关键词 乳腺肿瘤 凝血原时间 组织型纤溶酶激活物 维蛋白原 D-二聚体
下载PDF
纤维蛋白单体聚合功能与血栓前状态标志物在尿毒症透析前后的变化 被引量:3
5
作者 刘燕婕 王曦 付玲 《临床泌尿外科杂志》 2006年第8期621-622,624,共3页
目的:观察纤维蛋白单体聚合功能(FMPF)、组织型纤溶酶原激活物(tPA)及外周血浆因子Ⅷ相关抗原(vWFAg)在血液透析(HD)前后的改变及意义。方法:采用纤维蛋白单体聚合动力学检测法及酶联免疫吸附法(ELISA法)测定健康人及尿毒症患者HD前后的... 目的:观察纤维蛋白单体聚合功能(FMPF)、组织型纤溶酶原激活物(tPA)及外周血浆因子Ⅷ相关抗原(vWFAg)在血液透析(HD)前后的改变及意义。方法:采用纤维蛋白单体聚合动力学检测法及酶联免疫吸附法(ELISA法)测定健康人及尿毒症患者HD前后的FMPF、tPA和vWFAg的含量。结果:HD前后,肾病患者FMPV、Fbg、tPA及vWFAg的差异有统计学意义;HD前,FMPV、Fbg、vWFAg明显高于正常对照组(P<0.05),tPA明显低于正常对照组(P<0.05);HD后1h,FMPV、Fbg、vWFAg较HD前显著升高(P<0.05),tPA明显高于正常对照组(P<0.05);HD后24h,FMPV、Fbg、vWFAg的变化较HD前更为显著升高(P<0.01),tPA恢复至透析前水平。结论:肾功能衰竭患者的Fbg、vWFAg较正常人明显增高,经HD后进一步增高而致凝血机制过度激活,导致纤维蛋白沉积增多,加之HD后组织释放的活化剂使tPA显著降低,使肾静脉血栓的发生率提高,特别经多次HD者,更易发生肺栓塞。因此,以FMPF、vWFAg及tPA作为对肾病患者HD前后的病程进展及预后的评价指标,有一定的临床应用价值。 展开更多
关键词 尿毒症 血液透析 维蛋白单体聚合速率 组织型纤溶酶激活物
下载PDF
An Experimental Study of Pathogenesis of Steroid-induced Avascular Necrosis of Femoral Head 被引量:1
6
作者 李毅 陈君长 +3 位作者 康斌 王坤正 张珍妮 同志超 《Journal of Nanjing Medical University》 2003年第4期191-195,共5页
Objective: To explore the pathogenesis of avascular necrosis of femoral head(ANFH) and search an effective method for clinical practice. Methods: Twenty-four Japanese rabbitswere divided into 2 groups of models and co... Objective: To explore the pathogenesis of avascular necrosis of femoral head(ANFH) and search an effective method for clinical practice. Methods: Twenty-four Japanese rabbitswere divided into 2 groups of models and controls. ANFH models were produced byintramuscular-injection of large dosage of steroid to rabbits for 8 weeks. From the 4th, 8th and12th week after production of models, 2 rabbits of each group were sacrificed to observe thestructure of femoral head through light microscope and scanning electron microscope. The contents ofNitric Oxide (NO), tissue-type plasminogen activator (t-PA) and -plasminogen activator inhibitor(PAI) in plasma of the 4 rabbits in each group were estimated at the same time. Results: Comparedwith control group, the rabbits of model group exhibited many differences: such as osteoporosis offemoral head, the presence of more bone lacuna and fat cell through light microscope observing; thebroken and sunk bone trabecula, the loosen and broken collagen fibers on the surface of bone matrixthrough scanning electron microscope observing. Compared with control group, the Concentration ofNO and t-PA in plasma of the model rabbits decreased obviously, but the Concentration of the PAIincreased obviously. Conclusion: The steroid-induced ANFH might be related to the lower level of NOand the descent of fibrinolytic activity. 展开更多
关键词 femoral head necrosis pathological process nitric oxide tissue-typeplasminogen activator plasminogen activator inhibitor
下载PDF
The Role of Tissue-type Plasminogen Activator in Rat Corpus Luteum 被引量:2
7
作者 陈亚雄 陈宜峰 刘以训 《Developmental and Reproductive Biology》 1993年第1期28-32,共5页
It is here reported for the first time that luteal cells are capable of secreting plasminogen activators(PA),(both tissue-type,tPA,and urokinase-type,uPA),and plasminogen activator inhibitor type-1(PAl-1).Using organ ... It is here reported for the first time that luteal cells are capable of secreting plasminogen activators(PA),(both tissue-type,tPA,and urokinase-type,uPA),and plasminogen activator inhibitor type-1(PAl-1).Using organ culture model,we have demonstrated that tPA,but not uPA,showed markedchange during luteolytic period in rat corpus luteum.A great amount oftPA was secreted in corpusluteum on D 14 and D 17 while very low level of tPA activity was detected before D 12.Correspondingly,the progesterone production in the corpus luteum increased gradually in a time-dependent manner from D 1 to D 12 but dropped abruptly to a very low level on D 14.Additionof exogenous tPA to the CL culture caused considerable decrease in progesterone secretion whileinclusion of purified monoclone tPA antibodies in the culture augmented progesterone productionof CL.It is therefore suggested that tPA may play an important role in luteolytic process. 展开更多
关键词 Tissue-type plasminogen activator PROGESTERONE LUTEOLYSIS
下载PDF
胰岛素疗法对急性心肌梗塞合并糖尿病患者一年死亡率的影响(DIGAMI研究)
8
作者 谭宁 《岭南心血管病杂志》 1996年第2期21-21,共1页
胰岛素疗法对急性心肌梗塞合并糖尿病患者一年死亡率的影响(DIGAMI研究)[英]/MalmbergK…//JAmCoilCardiol-1995,26(1)~57~63急性心肌梗塞合并糖尿病患者的近期和远期死亡率都显... 胰岛素疗法对急性心肌梗塞合并糖尿病患者一年死亡率的影响(DIGAMI研究)[英]/MalmbergK…//JAmCoilCardiol-1995,26(1)~57~63急性心肌梗塞合并糖尿病患者的近期和远期死亡率都显著高于非糖尿病的急性心肌梗塞患者,... 展开更多
关键词 急性心肌梗塞 胰岛素疗法 合并糖尿病 年死亡率 组织激活物 使用胰岛素治疗 糖尿病患者 降低死亡率 非胰岛素依赖性糖尿病 急性心肌梗塞患者
下载PDF
Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients 被引量:1
9
作者 赵维莅 王学锋 +2 位作者 璩斌 黄霞萍 王鸿利 《Chinese Medical Journal》 SCIE CAS CSCD 2002年第5期702-704,150,共3页
OBJECTIVE: To evaluate variations in the plasma tissue factor (TF) and urokinase type plasminogen activator (u-PA) system and their relationship with clinical cancer type, pathological classification and metastatic st... OBJECTIVE: To evaluate variations in the plasma tissue factor (TF) and urokinase type plasminogen activator (u-PA) system and their relationship with clinical cancer type, pathological classification and metastatic status in cancer patients. METHODS: Plasma levels of TF and its inhibitor (TFPI), as well as u-PA and its receptor (u-PAR) were measured using ELISA in 76 patients with malignant tumors and 24 patients with benign tumors. RESULTS: Plasma levels of TF and u-PAR in the malignant tumor group were significantly higher than those of the benign tumor group and the normal control. U-PA and u-PAR increased significantly in patients with esophageal and gastric cancer. However, most of these parameters except TFPI did not vary according to pathological classification. A significant elevation was evident in patients with local infiltration, lymph node involvement and distal metastasis, while u-PAR only increased in the latter two categories. CONCLUSIONS: Both the TF and u-PA systems are activated in cancer patients. U-PA and its receptor might prove to be a clinically useful marker for disease progression. 展开更多
关键词 ADULT Aged Aged 80 and over Female Humans LIPOPROTEINS Male Middle Aged Neoplasm Metastasis NEOPLASMS Receptors Cell Surface Research Support Non-U.S. Gov't THROMBOPLASTIN Urinary Plasminogen Activator
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部